Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAT, MRR

United States Fertility Clinics Market Report to 2028: Increased Access to Infertility Care Presents Opportunities


DUBLIN, July 12, 2023 /PRNewswire/ -- The "U.S. Fertility Clinics Market" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo


The U.S. market for fertility clinic services was estimated at $7.9 billion in 2022 and is forecast to grow at a CAGR of 13.6% to reach $16.8 billion by the end of 2028. 

The U.S. fertility clinic market is in a crucial phase of transformation. There is still a great deal of uncertainty surrounding surrogacy and sperm donations, sometimes resulting in legal action due to inappropriate use of clinic consent forms. Using assisted reproductive technology (ART) to help women have babies is becoming more common but is still not very common compared to how many people want to use it. According to Centers for Diseases Control and Prevention, in the U.S., about 2% of all babies born each year are conceived with the help of ART.

Increasing awareness of fertility treatments as well as advances in technology and genetic testing are driving the growth of the market. According to the CDC's 2020 Fertility Clinic Success Rates Report, 326,468 ART cycles were performed in the U.S. at 449 reporting clinics. The number of ART cycles initiated rose from 163,045 cycles in 2011 to 326,468 in 2020. The number of egg banking cycles has also shown substantial growth, increasing from 11,116 in 2011 to 123,304 in 2020.

Two other trends driving the demand for fertility clinics are the increasing average age of new mothers and the increasing incidence of obesity. In addition, the rising number of single mothers and the growing LGBTQ population has stimulated the demand for specialized fertility techniques.

In this report, the market is segmented into ART, diagnostic services and surgeries. ART services are further segmented into in vitro fertilization (IVF), donor eggs, donor sperm, surrogacy and gamete intrafallopian transfer. Diagnostic services are segmented into hormone evaluation, semen analysis and new patient consultations.

The market for fertility clinics is a somewhat fragmented one, with 11 large players accounting for 17.2% of the market. Major players include CNY Fertility Center, Colorado Center for Reproductive Medicine (CCRM), Boston IVF LLC, New Hope Fertility Clinic, Reproductive Medicine Associates of New Jersey and NYU Langone Fertility Center.

ART accounted for a 79% share of the market for fertility clinics in 2022. The diagnostic services segment accounted for 15% of the market in 2022, while the surgeries segment accounted for 6%.

Market challenges include the lack of insurance coverage for infertility treatments, the risks of ART, and the high costs and failure rates of IVF.

Companies Mentioned

Report Includes

Key Attributes:

Report Attribute

Details

No. of Pages

89

Forecast Period

2023 - 2028

Estimated Market Value (USD) in 2023

$8.9 Billion

Forecasted Market Value (USD) by 2028

$16.8 Billion

Compound Annual Growth Rate

13.6 %

Regions Covered

United States

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Outlook

Chapter 4 Market Overview

Chapter 5 Emerging Trends in the U.S. Fertility Clinic Market

Chapter 6 Market Dynamics

Chapter 7 U.S. Fertility Clinics Market by Type

Chapter 8 U.S. Market for Fertility Drugs

Chapter 9 U.S. Fertility Clinics Market by End-user

Chapter 10 Regulatory Aspects

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/98ph91

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

10 mai 2024
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

10 mai 2024
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

10 mai 2024
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

10 mai 2024
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

10 mai 2024
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: